IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,304 | +61.8% | 25,369 | +78.8% | 0.01% | +60.0% |
| Q2 2023 | $150,961 | +186271.6% | 14,188 | +84.7% | 0.01% | +66.7% |
| Q1 2023 | $81 | -57.6% | 7,682 | -50.2% | 0.00% | -62.5% |
| Q4 2022 | $191 | -99.9% | 15,434 | -33.8% | 0.01% | +100.0% |
| Q3 2022 | $242,000 | -19.3% | 23,331 | -10.3% | 0.00% | -42.9% |
| Q2 2022 | $300,000 | +188.5% | 26,005 | +215.9% | 0.01% | +600.0% |
| Q1 2022 | $104,000 | -68.3% | 8,233 | -70.7% | 0.00% | -83.3% |
| Q4 2021 | $328,000 | +3.5% | 28,101 | +15.6% | 0.01% | -25.0% |
| Q3 2021 | $317,000 | +166.4% | 24,303 | +162.1% | 0.01% | +166.7% |
| Q2 2021 | $119,000 | -50.4% | 9,272 | -56.9% | 0.00% | -25.0% |
| Q1 2021 | $240,000 | +275.0% | 21,498 | +281.2% | 0.00% | +100.0% |
| Q4 2020 | $64,000 | -88.2% | 5,640 | -90.7% | 0.00% | -66.7% |
| Q3 2020 | $544,000 | +38.1% | 60,463 | +58.2% | 0.01% | -62.5% |
| Q2 2020 | $394,000 | +80.7% | 38,226 | +133.8% | 0.02% | -11.1% |
| Q4 2019 | $218,000 | +10800.0% | 16,350 | +8737.8% | 0.02% | – |
| Q2 2019 | $2,000 | -71.4% | 185 | -62.9% | 0.00% | -100.0% |
| Q4 2017 | $7,000 | -97.0% | 499 | -96.6% | 0.00% | -94.7% |
| Q3 2017 | $234,000 | – | 14,815 | +134581.8% | 0.02% | – |
| Q1 2017 | $0 | -100.0% | 11 | -99.6% | 0.00% | -100.0% |
| Q4 2016 | $46,000 | +31.4% | 2,984 | +33.9% | 0.01% | +66.7% |
| Q3 2016 | $35,000 | -27.1% | 2,229 | -39.5% | 0.00% | -40.0% |
| Q2 2016 | $48,000 | +700.0% | 3,682 | +597.3% | 0.01% | +400.0% |
| Q1 2016 | $6,000 | +500.0% | 528 | +319.0% | 0.00% | – |
| Q4 2015 | $1,000 | -75.0% | 126 | -69.3% | 0.00% | – |
| Q3 2015 | $4,000 | -66.7% | 410 | -59.7% | 0.00% | -100.0% |
| Q2 2015 | $12,000 | -87.6% | 1,018 | -83.2% | 0.00% | -91.7% |
| Q1 2015 | $97,000 | +708.3% | 6,045 | +663.3% | 0.01% | +1100.0% |
| Q4 2014 | $12,000 | – | 792 | +79100.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 1 | -99.9% | 0.00% | -100.0% |
| Q2 2014 | $14,000 | +600.0% | 879 | +486.0% | 0.00% | – |
| Q1 2014 | $2,000 | 0.0% | 150 | -25.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 200 | +27.4% | 0.00% | – |
| Q3 2013 | $2,000 | -94.6% | 157 | -95.8% | 0.00% | -100.0% |
| Q2 2013 | $37,000 | – | 3,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |